Caribou Biosciences Potential Upside
| CRBU Stock | | | USD 1.88 -0.07 -3.59% |
Potential Upside is the amount of upward price movement an investor or an analyst expects of a particular equity instrument. Below is Caribou Biosciences's current Potential Upside with peer comparisons and related risk metrics.
Current Potential Upside Value
At 8.64, Caribou Biosciences exhibits moderate estimated upside from current levels in Potential Upside. Caribou Biosciences trades below the model-derived fair value estimate by a meaningful margin.
Potential Upside | = | 1PM2PM |
| = | 8.64 | |
| 1PM | = | First upper moment |
| 2PM | = | Second upper moment |
Potential Upside Peers Comparison
Relative to peers, Caribou Biosciences's Potential Upside is below the group average of 9.16. Peer readings range from 4.16 (Enanta Pharmaceuticals) to 19.57 (Prelude Therapeutics), reflecting wide dispersion across the sector. Caribou Biosciences shows less estimated upside from current levels than the peer average.
Potential Upside Relative To Other Indicators
The chart below plots Potential Upside against Maximum Drawdown for Caribou Biosciences and its peers. Each point represents one equity — position along the horizontal axis shows Potential Upside while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Potential Upside (
8.64 ) to Maximum Drawdown (
20.34 ) for Caribou Biosciences yields a
2.35 multiple. This indicates Maximum Drawdown is significantly higher than Potential Upside for Caribou Biosciences.
Methodology, Assumptions & Data Sources
Caribou Biosciences' Potential Upside currently stands at 8.64. This Potential Upside reading for Caribou Biosciences results from applying the indicator's calculation rules to price and volume data over the selected window. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. Caribou Biosciences operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators